SCHEMBL853770

SCHEMBL853770

COC(=O)CC(c1cccnc1)c1c[nH]c2ccc(OCCc3cccc(N(C)C(=O)OC(C)(C)C)n3)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
MTNR1A P48039 5/20 0.35
MTNR1B P49286 5/20 0.35
ITGB3 P05106 2/20 0.34
ITGAV P06756 2/20 0.34
ITGB5 P18084 2/20 0.34
USP2 O75604 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CLK4 Q9HAZ1 2/20 0.33
ITGB1 P05556 2/20 0.33
ITGA5 P08648 2/20 0.33
KCNA5 P22460 5/20 0.33
LTA4H P09960 1/20 0.32
PLA2G2A P14555 1/20 0.32
MGAM O43451 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853670 0.87 NR1H2 (0.36) NR1H2NR1H3MTNR1AMTNR1BITGB3
SCHEMBL852538 0.84 ITGB3 (0.47) MTNR1AMTNR1BITGB3ITGAVITGB5
SCHEMBL853983 0.82 ITGB3 (0.35) NR1H2NR1H3MTNR1AMTNR1BITGB3
SCHEMBL852464 0.79 NR4A2 (0.36) MTNR1AMTNR1BUSP2CYP1A2CYP3A4
SCHEMBL860965 0.79 ITGB3 (0.52) ITGB3ITGAVITGB5
SCHEMBL852473 0.79 ITGB3 (0.52) MTNR1AMTNR1BITGB3ITGAVITGB5
SCHEMBL861190 0.73 MAOA (0.42) NR1H2NR1H3MTNR1AMTNR1BITGB3
SCHEMBL853915 0.71 HTT (0.35) MTNR1AMTNR1BCYP1A2CYP2C9CYP2C19
SCHEMBL853781 0.70 ITGB3 (0.51) MTNR1AMTNR1BITGB3ITGAVITGB5
SCHEMBL853153 0.70 ITGB3 (0.59) MTNR1AMTNR1BITGB3ITGAVITGB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed